Apoplogic Pharmaceuticals Inc
ApopLogic Pharmaceuticals Inc., located in Aurora, CO, specializes in developing and commercializing innovative therapeutics for the treatment of solid tumors. Their primary products, B201-acetate and AP-300, are designed to target specific cancer biomarkers and have shown potential in both human and animal health applications.
The company is actively seeking partners and funding to advance B201-acetate through phase 2 clinical trials and to bring AP-300 to market as a veterinary oncology product. With a strong focus on addressing high unmet medical needs, ApopLogic aims to attract investment to facilitate comprehensive product development for its promising cancer therapies.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
